UBS Group’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $36.9K | Buy |
|
|||||
|
2025
Q2 | $26K | Sell |
|
|||||
|
2025
Q1 | $57K | Sell |
|
|||||
|
2024
Q4 | $138K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $11.7K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $2.81K | Sell |
|
|||||
|
2023
Q1 | $6.4K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $5K | Buy |
|
|||||
|
2022
Q2 | $0 | Sell |
|
|||||
|
2022
Q1 | $8K | Sell |
|
|||||
|
2021
Q4 | $28K | Buy |
|
|||||
|
2021
Q3 | $41K | Buy |
|
|||||
|
2021
Q2 | $32K | Buy |
|
|||||
|
2021
Q1 | $15K | Sell |
|
|||||
|
2020
Q4 | $24K | Sell |
|
|||||
|
2020
Q3 | $29K | Buy |
|
|||||
|
2020
Q2 | $30K | Sell |
|
|||||
|
2020
Q1 | $31K | Sell |
|
|||||
|
2019
Q4 | $71K | Sell |
|
|||||
|
2019
Q3 | $27K | Buy |
|
|||||
|
2019
Q2 | $0 | Sell |
|
|||||
|
2019
Q1 | $6K | Sell |
|
|||||
|
2018
Q4 | $976K | Buy |
|
|||||
|
2018
Q3 | $16K | Sell |
|
|||||
|
2018
Q2 | $67K | Buy |
|
|||||
|
2018
Q1 | $22K | Sell |
|
|||||
|
2017
Q4 | $25K | Sell |
|
|||||
|
2017
Q3 | $40K | Buy |
|
|||||
|
2017
Q2 | $26K | Sell |
|
|||||
|
2017
Q1 | $40K | Buy |
|
|||||
|
2016
Q4 | $29K | Buy |
|
|||||
|
2016
Q3 | $43K | Buy |
|